Discovery and Mediclinic scale back plans for vaccine sites amid supply concerns
The companies put brakes on new sites as only 1.3-million Pfizer doses delivered
28 May 2021 - 05:08
Discovery and Mediclinic, two of the country’s key private sector operators, have put the brakes on plans to expand their coronavirus vaccination sites, as concern grows over looming supply constraints.
SA’s vaccination campaign launched on May 17, after delays and unexpected setbacks that included a last-minute hold on the release of Johnson & Johnson’s (J&J) single-shot jab, which was intended to be the backbone of the programme. Sites are dispensing only Pfizer’s double-shot vaccine...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.